Welcome to LookChem.com Sign In|Join Free
  • or
(4R)-1-METHYL-4-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-OL, also known as (4R)-1-Methyl-4-isopropenylcyclohex-2-en-1-ol, is a chemical reagent with a unique molecular structure characterized by a cyclohexenol core and two methyl groups. It is known for its potential applications in the synthesis of various compounds, particularly in the pharmaceutical and chemical industries.

861892-40-2

Post Buying Request

861892-40-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

861892-40-2 Usage

Uses

Used in Pharmaceutical Industry:
(4R)-1-METHYL-4-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-OL is used as a chemical reagent for the synthesis of Δ8-THC cannabinoid analogs with activity against CB receptors. These analogs have potential therapeutic applications in treating various medical conditions, such as pain management, inflammation, and neurological disorders.
Used in Chemical Industry:
(4R)-1-METHYL-4-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-OL is also used as an intermediate in the synthesis of other complex organic compounds, contributing to the development of new materials and chemical products. Its unique structure allows for versatile chemical reactions, making it a valuable component in the creation of novel molecules with potential applications in various fields.

Check Digit Verification of cas no

The CAS Registry Mumber 861892-40-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,1,8,9 and 2 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 861892-40:
(8*8)+(7*6)+(6*1)+(5*8)+(4*9)+(3*2)+(2*4)+(1*0)=202
202 % 10 = 2
So 861892-40-2 is a valid CAS Registry Number.

861892-40-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (4R)-1-methyl-4-prop-1-en-2-ylcyclohex-2-en-1-ol

1.2 Other means of identification

Product number -
Other names (4R)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-2-enol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:861892-40-2 SDS

861892-40-2Synthetic route

(4R)-limonene 1,2-epoxide
1195-92-2

(4R)-limonene 1,2-epoxide

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

Conditions
ConditionsYield
Stage #1: (4R)-limonene 1,2-epoxide With sodium tetrahydroborate; diphenyl diselenide In ethanol for 2h; Heating;
Stage #2: With dihydrogen peroxide In tetrahydrofuran for 2h; Heating;
52%
Stage #1: (4R)-limonene 1,2-epoxide With sodium tetrahydroborate; ethanol; diphenyl diselenide at 0℃; Reflux; Inert atmosphere;
Stage #2: With dihydrogen peroxide In tetrahydrofuran; water at 0℃; Reflux;
52%
Stage #1: (4R)-limonene 1,2-epoxide With sodium tetrahydroborate; diphenyl diselenide at 0℃;
Stage #2: With dihydrogen peroxide at 0℃; Further stages.;
28%
D-limonene
5989-27-5

D-limonene

A

(2S,4S)-carveol
7632-16-8

(2S,4S)-carveol

B

(+)-trans-carveol
2102-58-1

(+)-trans-carveol

C

(R)-Perillyl alcohol
57717-97-2

(R)-Perillyl alcohol

D

(5S)-2-methylene-5-(prop-1-en-2-yl)cyclohexanol
216655-62-8

(5S)-2-methylene-5-(prop-1-en-2-yl)cyclohexanol

E

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

Conditions
ConditionsYield
Stage #1: D-limonene With C48H42N2O4S5 In acetonitrile for 0.5h; Irradiation;
Stage #2: With sodium tetrahydroborate In ethanol at 0℃; Darkness;
Stage #3: With water In ethanol
D-limonene
5989-27-5

D-limonene

A

5-Isopropenyl-2-methyl-cyclohex-2-enol
99-48-9

5-Isopropenyl-2-methyl-cyclohex-2-enol

B

(5R)-2-methylene-5-(1-methylethenyl)-1-cyclohexanol
216655-61-7

(5R)-2-methylene-5-(1-methylethenyl)-1-cyclohexanol

C

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

Conditions
ConditionsYield
Stage #1: D-limonene With sodium molybdate dihydrate; dihydrogen peroxide; sodium hydroxide In methanol; water for 0.583333h; pH=10; Heating;
Stage #2: With sodium sulfite In methanol; water at 60℃; for 3h; Reagent/catalyst;
carbon dioxide
124-38-9

carbon dioxide

cis-(R)-limonene oxide
4680-24-4

cis-(R)-limonene oxide

A

L-carveol
308363-12-4

L-carveol

B

(R)-dihydrocarvone
116499-64-0

(R)-dihydrocarvone

C

1-methyl-4-(1-methylethenyl)-1,2-cyclohexanediol
185329-56-0

1-methyl-4-(1-methylethenyl)-1,2-cyclohexanediol

D

(5R)-2-methylene-5-(1-methylethenyl)-1-cyclohexanol
216655-61-7

(5R)-2-methylene-5-(1-methylethenyl)-1-cyclohexanol

E

C11H16O3

C11H16O3

F

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

Conditions
ConditionsYield
With tetrabutylammomium bromide; 3C25H54N(1+)*O24PW4(3-) In neat (no solvent) at 140℃; for 24h; Reagent/catalyst; High pressure; Autoclave;
carbon dioxide
124-38-9

carbon dioxide

(1S,2R,4R)-limonene-1,2-epoxide
6909-30-4

(1S,2R,4R)-limonene-1,2-epoxide

A

L-carveol
308363-12-4

L-carveol

B

1-methyl-4-(1-methylethenyl)-1,2-cyclohexanediol
185329-56-0

1-methyl-4-(1-methylethenyl)-1,2-cyclohexanediol

C

(5R)-2-methylene-5-(1-methylethenyl)-1-cyclohexanol
216655-61-7

(5R)-2-methylene-5-(1-methylethenyl)-1-cyclohexanol

D

(R)-(+)-limonene carbonate

(R)-(+)-limonene carbonate

E

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

Conditions
ConditionsYield
With tetrabutylammomium bromide; 3C25H54N(1+)*O24PW4(3-) In neat (no solvent) at 140℃; for 24h; Reagent/catalyst; High pressure; Autoclave;
2-(3,5-dihydroxyphenyl)-2-methylhexane
22930-09-2

2-(3,5-dihydroxyphenyl)-2-methylhexane

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

(6aR,10aR)-6,6,9-trimethyl-3-(2-methylhexan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol
22663-41-8

(6aR,10aR)-6,6,9-trimethyl-3-(2-methylhexan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol

Conditions
ConditionsYield
With toluene-4-sulfonic acid In toluene at 20 - 80℃; for 7h; Dean-Stark;85.5%
With toluene-4-sulfonic acid In benzene for 12h; Reflux;
(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

5-(1-hexylcyclopentyl)resorcinol
487578-68-7

5-(1-hexylcyclopentyl)resorcinol

5-(1-Hexyl-cyclopentyl)-2-((1R,6R)-6-isopropenyl-3-methyl-cyclohex-2-enyl)-benzene-1,3-diol
1025965-31-4

5-(1-Hexyl-cyclopentyl)-2-((1R,6R)-6-isopropenyl-3-methyl-cyclohex-2-enyl)-benzene-1,3-diol

Conditions
ConditionsYield
With toluene-4-sulfonic acid In benzene at 10 - 20℃; for 1h;85%
5-(1-adamantanyl)resorcinol
60526-91-2

5-(1-adamantanyl)resorcinol

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

AM411

AM411

Conditions
ConditionsYield
With toluene-4-sulfonic acid In chloroform at 65℃; for 6h;84%
methyl 2,4-dihydroxy-6-pentylbenzoate
58016-28-7

methyl 2,4-dihydroxy-6-pentylbenzoate

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

methyl (1'R,2'R)-2,6-dihydroxy-5'-methyl-4-pentyl-2'-(prop-1 -en-2- yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-3-carboxylate
55658-71-4

methyl (1'R,2'R)-2,6-dihydroxy-5'-methyl-4-pentyl-2'-(prop-1 -en-2- yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-3-carboxylate

Conditions
ConditionsYield
Stage #1: methyl 2,6-dihydroxy-6-pentylbenzoate; (4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol With boron trifluoride diethyl etherate In chlorobenzene at 22℃;
Stage #2: With sodium hydrogencarbonate In chlorobenzene at 20℃; for 0.333333h;
70%
With boron trifluoride diethyl etherate In chlorobenzene at 20℃; for 1h; Reagent/catalyst; Temperature; Solvent;70%
Stage #1: methyl 2,6-dihydroxy-6-pentylbenzoate; (4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol With boron trifluoride diethyl etherate In chlorobenzene at 22℃; Flow reactor;
Stage #2: With sodium hydrogencarbonate In chlorobenzene at 22℃; for 0.333333h;
With boron trifluoride diethyl etherate In chlorobenzene at 20℃; for 1h; Solvent;
5-(8-bromo-2-methyloctan-2-yl)benzene-1,3-diol
160512-71-0

5-(8-bromo-2-methyloctan-2-yl)benzene-1,3-diol

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

(-)-7′-bromo-1',1'-dimethylheptyl-Δ8-tetrahydrocannabinol

(-)-7′-bromo-1',1'-dimethylheptyl-Δ8-tetrahydrocannabinol

Conditions
ConditionsYield
With toluene-4-sulfonic acid In benzene for 4h; Reflux;65%
5-(2,5,5-trimethyl-1,3-dioxan-2-yl) benzene-1,3-diol

5-(2,5,5-trimethyl-1,3-dioxan-2-yl) benzene-1,3-diol

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

1-((2'R)-2,6-dihydroxy-5'-methyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-4-yl)ethan-1-one

1-((2'R)-2,6-dihydroxy-5'-methyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-4-yl)ethan-1-one

Conditions
ConditionsYield
With boron trifluoride diethyl etherate; magnesium sulfate In dichloromethane at -10 - 0℃; for 3h; Inert atmosphere;62%
5-(2-methyl-1,3-dithiolan-2-yl)benzene-1,3-diol

5-(2-methyl-1,3-dithiolan-2-yl)benzene-1,3-diol

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

(2'R)-5'-methyl-4-(2-methyl-1,3-dithiolan-2-yl)-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-2,6-diol

(2'R)-5'-methyl-4-(2-methyl-1,3-dithiolan-2-yl)-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-2,6-diol

Conditions
ConditionsYield
With toluene-4-sulfonic acid In benzene at 20℃; for 1h; Inert atmosphere;58.5%
5-(2-adamantyl)methylresorcinol
861892-38-8

5-(2-adamantyl)methylresorcinol

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

AM757

AM757

Conditions
ConditionsYield
With toluene-4-sulfonic acid In chloroform at 65℃; for 6h;57%
4-(3,5-dihydroxyphenyl)-1-bromobutane
1260669-57-5

4-(3,5-dihydroxyphenyl)-1-bromobutane

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

A

5-(4-bromobutyl)-4-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol
1260669-54-2

5-(4-bromobutyl)-4-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol

B

5-(4-bromobutyl)-4-[(1S,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol
1305300-52-0

5-(4-bromobutyl)-4-[(1S,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol

C

5-(4-bromobutyl)-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol
1260669-38-2

5-(4-bromobutyl)-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol

Conditions
ConditionsYield
With boron trifluoride diethyl etherate; magnesium sulfate In dichloromethane at -40℃; for 1h; Inert atmosphere;A 50%
B 33%
C 17%
(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

Olivetol
500-66-3

Olivetol

Δ8-tetrahydrocannabinol

Δ8-tetrahydrocannabinol

Conditions
ConditionsYield
With toluene-4-sulfonic acid In water; benzene for 2h; Reflux;49%
5-(2-adamantanyl)resorcinol
861892-36-6

5-(2-adamantanyl)resorcinol

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

AM744

AM744

Conditions
ConditionsYield
With toluene-4-sulfonic acid In chloroform at 65℃; for 6h;48.5%
1-(3,5-dihydroxyphenyl)cyclobutanecarboxylic acid
1314744-72-3

1-(3,5-dihydroxyphenyl)cyclobutanecarboxylic acid

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

1-[(6aR,10aR)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-3-yl]cyclobutanecarboxylic acid
1510836-51-7

1-[(6aR,10aR)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-3-yl]cyclobutanecarboxylic acid

Conditions
ConditionsYield
With toluene-4-sulfonic acid In chloroform for 6h; Inert atmosphere; Reflux;45%
5-(1-adamantyl)methylresorcinol
861892-39-9

5-(1-adamantyl)methylresorcinol

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

AM 729

AM 729

Conditions
ConditionsYield
With toluene-4-sulfonic acid In chloroform at 65℃; for 6h;43.4%
(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol
861892-40-2

(4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-en-1-ol

5-[2-hexyl-1,3-dithian-2-yl]resorcinol
579444-48-7

5-[2-hexyl-1,3-dithian-2-yl]resorcinol

5-(2-Hexyl-[1,3]dithian-2-yl)-2-((1R,6R)-6-isopropenyl-3-methyl-cyclohex-2-enyl)-benzene-1,3-diol
1027023-77-3

5-(2-Hexyl-[1,3]dithian-2-yl)-2-((1R,6R)-6-isopropenyl-3-methyl-cyclohex-2-enyl)-benzene-1,3-diol

Conditions
ConditionsYield
With toluene-4-sulfonic acid In benzene at 10 - 20℃; for 1h;43%

861892-40-2Relevant academic research and scientific papers

PROCESS FOR THE SYNTHESIS OF CANNABIDIOL AND INTERMEDIATES THEREOF

-

Paragraph 0059, (2021/09/17)

The present invention relates to process for the preparation of cannabidiol (A) from the coupling of (D) and (E) through the intermediates (C) and (D) starting from compound (B). The invention further relates to the novel compounds (B), (C), (D) and (E) and reagents used in this process. More specifically, this invention provides the manufacturing of Cannabidiol (A) in milligram to gram or kilogram scale.

Method for continuously preparing cannabidiol intermediate through green photooxidation

-

Paragraph 0077-0112, (2021/05/19)

The invention provides a method for continuously preparing a cannabidiol intermediate compound (4R)-1-methyl-4-(2-(1-propylene))-2-cyclohexene-2-ol (formula III) through photooxidation, which comprises the following steps: taking (R)-(+)-limonene (formula I-a) as an initial raw material, carrying out continuous photooxidation reaction in a photoreactor to obtain peroxide, and then carrying out reduction reaction to obtain an intermediate III. The technical route is simple and easy to implement, conditions are mild, column separation and purification are not needed, the production cost is greatly reduced, and industrial production is convenient to implement. The cannabidiol intermediate compound III is prepared by using a simple synthesis route, and the method has the advantages of simple process, less pollution, easiness in purification and the like.

Method for continuously preparing cannabidiol intermediate through green photooxidation

-

Paragraph 0016; 0028-0029; 0038-0051, (2021/07/31)

The invention relates to a novel method for synthesizing cannabidiol (-)-Cannabidiol (CBD, formula I), aiming at solving the defects in the prior art. The production process is characterized by comprising the following steps that: (R)-(+)-Limonene (compound I-a) is adopted as an initial raw material; the initial raw material and a photocatalyst are subjected to an oxidation reaction under illumination,and then a reduction reaction is performed; and a pure key intermediate I-e is obtained through purification. The reaction formula involved in the steps is shown in the specification. The reaction and purification are simple; The method of the invention has the advantages of simple and easy-to-implement technical route, wide raw material source range, mild conditions, low production cost, high yield and environment-friendly performance, and provides a more effective synthesis method for industrial production.

Selective Catalytic Synthesis of 1,2- and 8,9-Cyclic Limonene Carbonates as Versatile Building Blocks for Novel Hydroxyurethanes

Maltby, Katarzyna A.,Hutchby, Marc,Plucinski, Pawel,Davidson, Matthew G.,Hintermair, Ulrich

supporting information, p. 7405 - 7415 (2020/05/25)

The selective catalytic synthesis of limonene-derived monofunctional cyclic carbonates and their subsequent functionalisation via thiol–ene addition and amine ring-opening is reported. A phosphotungstate polyoxometalate catalyst used for limonene epoxidation in the 1,2-position is shown to also be active in cyclic carbonate synthesis, allowing a two-step, one-pot synthesis without intermittent epoxide isolation. When used in conjunction with a classical halide catalyst, the polyoxometalate increased the rate of carbonation in a synergistic double-activation of both substrates. The cis isomer is shown to be responsible for incomplete conversion and by-product formation in commercial mixtures of 1,2-limomene oxide. Carbonation of 8,9-limonene epoxide furnished the 8,9-limonene carbonate for the first time. Both cyclic carbonates underwent thiol–ene addition reactions to yield linked di-monocarbonates, which can be used in linear non-isocyanate polyurethanes synthesis, as shown by their facile ring-opening with N-hexylamine. Thus, the selective catalytic route to monofunctional limonene carbonates gives straightforward access to monomers for novel bio-based polymers.

OXIDATION OF LIMONENE

-

Paragraph 0043; 0045; 0046, (2018/06/15)

The invention discloses a process for the oxidation of limonene, comprising the reaction of limonene with hydrogen peroxide in the presence of a catalyst containing atoms and/or ions of at least one metal, selected from the group consisting of molybdenum, tungsten, scandium, vanadium, titanium, lanthanum, zirconium, praseodymium, neodymium, samarium, europium, terbium, dysprosium, erbium or ytterbium, characterised in that the molecular weight of the catalyst is less than 2,000 g/mol and that the reaction is performed at a pH value of more than 7.5.

Photooxidation and phototoxicity of π-extended squaraines

Rapozzi, Valentina,Beverina, Luca,Salice, Patrizio,Pagani, Giorgio A.,Camerin, Monica,Xodo, Luigi E.

experimental part, p. 2188 - 2196 (2010/08/06)

This paper describes the synthesis of π-extended squaraines and their photooxidation properties and gives an in-depth characterization of these molecules as photosensitizing agents. Squaraines show a strong absorption in the tissue transparency window (600-800 nm), and upon irradiation, they undergo a photooxidation process, leading to the formation of peroxide and hydroperoxide radicals according to a type I radical chain process. Confocal laser microscopy demonstrates that the designed squaraines efficiently internalize in the cytoplasm and not in the nucleus of the cell. In the dark, they are scarcely cytotoxic, but after irradition, they promote a strong dose-dependent phototoxic effect in four different cancer cells. In HeLa and MCF-7 cells, squaraines 4 and 5, thanks to their hydrocarbon tails, associate to the membranes and induce lipid peroxidation, as indicated by a marked increase of malonyldialdehyde after photodynamic treatment, in agreement with in vitro photooxidation studies. FACS, caspase-3/7 assays and time-lapse microscopy demonstrate that the designed squaraines cause cell death primarily by necrosis.

FLUORINATION OF ORGANIC COMPOUNDS

-

Page/Page column 69;70, (2010/07/10)

Methods for fluorinating organic compounds are described herein.

Antibody-catalyzed oxidation of Δ9-tetrahydrocannabinol

Brogan, Andrew P.,Eubanks, Lisa M.,Koob, George F.,Dickerson, Tobin J.,Janda, Kirn D.

, p. 3698 - 3702 (2008/01/01)

Marijuana abuse continues to plague society and the lack of effective treatments warrants concern. Catalytic antibodies capable of oxidatively degrading the major psychoactive component of marijuana, Δ9- tetrahydrocannabinol (Δ9-THC), are presented. The antibodies generate reactive oxygen species from singlet oxygen (1O 2*), using riboflavin (vitamin B2) and visible light as the 1O2*source. Cannabitriol was identified as the major degradation product of this reaction, demonstrating the ability of an antibody to catalyze a complex chemical transformation with therapeutic implications for treating marijuana abuse.

Δ9-tetrahydrocannabinol immunochemical studies: Haptens, monoclonal antibodies, and a convenient synthesis of radiolabeled Δ9-tetrahydrocannabinol

Qi, Longwu,Yamamoto, Noboru,Meijler, Michael M.,Altobell III, Laurence J.,Koob, George F.,Wirsching, Peter,Janda, Kim D.

, p. 7389 - 7399 (2007/10/03)

Immunopharmacotherapy as an approach to combat drugs of abuse has become an active area of investigation. Marijuana is the most commonly used illicit drug in the U.S. The main active chemical in marijuana is Δ9- tetrahydrocannabinol (Δ9-THC); hence, monoclonal antibodies with high affinity and specificity for Δ9-tetrahydrocannabinol could be valuable immunopharmacotherapeutic intervention and diagnostic tools. We have synthesized immunoconjugates that induce an effective immune response to Δ9-THC and describe a convenient synthesis of radiolabeled Δ9-THC. We demonstrate the value and use of this probe to select anti-Δ9-THC antibodies that bind Δ9-THC with good affinity. The synthetic route to radiolabeled Δ9-THC has enabled the correct assessment of the affinity of these antibodies to their ligand and may facilitate future binding studies between Δ9- THC and its analogues and the cannabinoid receptors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 861892-40-2